Description
The Antibiotics Platform Meeting 2024 provided first-hand insights into the challenges of bringing novel antibiotics through the clinical stages and created a stimulating environment for scientific exchange and networking among antibiotics experts of diverse backgrounds.
Quick Facts
- Date and location: September 25, 2024, Zürich
- Participants: 22, including 10 academic, 10 industrial, 2 clinical
- Presentations: 10
- Sponsors: Biotechnet, UZH Institute of Medical Microbiology
- Organized by: PD Oliver Nolte (BioLAGO e.V.), and Prof. Markus Seeger (UZH)
Presentations
- Dr. Damien Morger, rqmicro AG, Schlieren: “E. coli Monitoring using Nanobodies with Broad Species Coverage”
- Dr. Shawna McCallin, Balgrist: “A two phage cocktail for the treatment of UTI”
- Prof. Oliver Zerbe, UZH: “Very potent macrocyclic peptide antibiotics directed against a novel target, the LPS transport pathway”
- Prof. Pilar Junier, Uni Neuchatel: “Exploiting microbial interactions to fight fungal pathogens in the respiratory track”
- Dr. Michel Pieren, Bioversys, Basel: “AlpE – a novel drug combination for treatment of TB”
- Prof. Christoph Dehio, NCCR Antiresist: “Physiological in vitro models for studying the pathogenesis and treatment of urinary tract infections”
- Dr. Alexander Kettner, Olgram, Geneva: “Development of persister platform to tackle the chronicity of infections”
- Prof. Jörg Jores, VetSuisse Berne: ”Synthetic Genomics-based Organisms to Assist AMR Control”
- Dr. Markus Huemer, Micreos: “Micreos Pharmaceuticals- engineering precision antimicrobials”
- Prof. Steffi Lehmann, ZHAW: “A zebrafish larvae-based platform for antimicrobial efficacy screening”
- PD Oliver Nolte, UZH, Zurich: „Automation and digitalization in the clinical microbiology laboratory – challenges and opportunities“
Next Event
- Indo-Swiss AMR Innovation Dialogue
- April 28-29, 2025
- Swiss Re Centre for Global Dialogue, Rüschlikon
